Complicated case of
Conjunctivitis
Mycobacterium
Sjögren's syndrome
Journal
American journal of ophthalmology case reports
ISSN: 2451-9936
Titre abrégé: Am J Ophthalmol Case Rep
Pays: United States
ID NLM: 101679941
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
11
06
2019
revised:
13
05
2020
accepted:
31
05
2020
entrez:
18
6
2020
pubmed:
18
6
2020
medline:
18
6
2020
Statut:
epublish
Résumé
To report a case of conjunctivitis due to Mycobacterium abscessus in the setting of keratoconjunctivitis sicca due to Sjögren's syndrome in the absence of other known risk factors such as surgery, trauma or immunosuppressive therapy. A 61-year-old woman with a history of keratoconjunctivitis sicca secondary to Sjögren's syndrome presented with dryness, irritation, redness, and discharge in her left eye for 2 months. She was diagnosed with chronic conjunctivitis and began a regimen of moxifloxacin and an ocular ointment of dexamethasone, neomycin, and polymyxin with no improvement of symptoms. Concurrent cultures grew Mycobacterium abscessus and the patient began treatment with amikacin drops, oral clarithromycin and intravenous imipenem, followed by amikacin drops, oral clarithromycin, and oral clofazimine, but her course was complicated by a perforated corneal ulcer that required a corneal patch graft. The patient eventually recovered despite persistent colonization. We present a case of Mycobacterium abscessus conjunctivitis in a patient with keratoconjunctivitis sicca secondary to Sjögren's syndrome without previous history of surgery, trauma, or other known risk factors. Because of low suspicion and clinician awareness, ocular nontuberculous mycobacteria (NTM) infection may have a delayed diagnosis and treatment. Clinicians should consider NTM in the differential diagnosis in patients with autoimmune disease such as Sjögren's syndrome. Treatment may be lengthy, requiring topical and systemic antibiotics and is often complicated due to resistance.
Identifiants
pubmed: 32548334
doi: 10.1016/j.ajoc.2020.100765
pii: S2451-9936(20)30116-X
pii: 100765
pmc: PMC7286968
doi:
Types de publication
Case Reports
Langues
eng
Pagination
100765Informations de copyright
© 2020 The Authors. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
None of the authors have conflicts of interest related to the present work.
Références
Surv Ophthalmol. 2012 May-Jun;57(3):202-35
pubmed: 22516536
PLoS One. 2017 May 9;12(5):e0176549
pubmed: 28486537
BMC Infect Dis. 2017 Dec 28;17(1):796
pubmed: 29282007
Biomed Res Int. 2015;2015:164989
pubmed: 26106601
Emerg Infect Dis. 2015 Sep;21(9):1638-46
pubmed: 26295364
Eur J Ophthalmol. 2008 Mar-Apr;18(2):294-6
pubmed: 18320526
Clin Exp Ophthalmol. 2008 May;36(4):371-3
pubmed: 18700926
J Antimicrob Chemother. 2005 Feb;55(2):170-7
pubmed: 15590712
Invest Ophthalmol Vis Sci. 1983 May;24(5):623-30
pubmed: 6841010
Arch Ophthalmol. 2000 Aug;118(8):1125-8
pubmed: 10922212
J Formos Med Assoc. 2014 Oct;113(10):760-1
pubmed: 25240307
Arch Ophthalmol. 1973 Dec;90(6):470-2
pubmed: 4759435
Ophthalmic Plast Reconstr Surg. 2004 Mar;20(2):168-70
pubmed: 15083089
Arch Ophthalmol. 1980 Jan;98(1):89-94
pubmed: 7352872